EU Accepts Sanofi’s Concessions to End Antitrust Probe Over Vaccine Marketing

The European Union has agreed to Sanofi's commitments to resolve antitrust concerns regarding its marketing practices for flu vaccines, ending a long-standing probe. The French pharmaceutical giant has made concessions to ensure its past marketing strategies do not unfairly impact competitors. This resolution is significant as it underscores the EU's commitment to fair competition in the healthcare sector, ensuring that companies adhere to ethical marketing standards to protect public health and market integrity.